Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2019

Every FDA drug recall initiated in 2019, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,788 recalls, newest first.

Class III · Low risk

Smart Sense Regular Strength Aspirin Tablets

Labeling; Incorrect or Missing Lot Number and/or Exp Date; Product has an incorrect expiration date of 9/2022 applied to the labeling, where the actual expiration date is 10/2021.

Terminated Stability / shelf life AAA Pharmaceutical, Inc. D-1585-2019
Class II · Moderate risk

Diphenhydramine HCL Liquid

Microbial Contamination of Non-sterile Products: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination H J Harkins Company Inc dba Pharma Pac NDC 52959-0123-03 D-1430-2019
Class II · Moderate risk

Acetaminophen Children's Liquid

Microbial Contamination of Non-sterile Products: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination H J Harkins Company Inc dba Pharma Pac NDC 52959-0309-04 D-1429-2019
Class II · Moderate risk

Workvie Instant Pain Relieving Roll On

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 72393-201-25 D-1507-2019
Class II · Moderate risk

Neogen-D

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 52083-699-16 D-1506-2019
Class II · Moderate risk

Sorbugen Nr

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 52083-660-16 D-1505-2019
Class II · Moderate risk

Tusslin

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 52083-622-16 D-1504-2019
Class II · Moderate risk

Dayma SUPER FORTE XL10

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 63788-118-04 D-1503-2019

Recalls by year